Celanese announces grant award to develop long-acting, refillable drug delivery solution

Dallas--(business wire)---- $ce--celanese corporation (nyse: ce), a global chemical and specialty materials company, today announced receipt of a grant from the bill & melinda gates foundation to produce and characterize a working prototype for a refillable contraceptive implant. the research and development will be conducted within the celanese pharmaceutical development and feasibility lab and the project is expected to produce a functional prototype that meets all established project parameters
CE Ratings Summary
CE Quant Ranking